Among the 14 patients with stage II or III carcinomas,
nine (64%) died from recurrence after a median of 8
months (range, 4 to 16 months), two are alive without
recurrence after 20 and 98 months, and three died without
recurrence after 3, 9, and 10 months. Among the seven
patients with incidental multifocal BAC, three died from
recurrence; one is alive with recurrence in the transplanted
lung; two are alive without recurrence 9 and 49 months after
transplantation, respectively; and one died without recurrence
2 months postoperatively.